This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of ropinirole
PDMED_ROPINIROLE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1209 |
4. Check minimum number of events
Min. number of events
3
|
1209 |
5. Include endpointsNone |
1209 |
6. Filter based on genotype QC (FinnGen only) |
1209 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Use of ropinirole
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1209 | 549 | 660 |
| Unadjusted period prevalence (%) | 0.24 | 0.19 | 0.29 |
| Median age at first event (years) | 64.00 | 63.59 | 64.35 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1047
- Matched controls
- 10468
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G20
ICD-10 Finland
Parkinson disease
341.1
323.0
866
143
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
254.4
323.0
415
27
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
391.9
323.0
872
130
N04BD01
ATC
selegiline; oral
257.4
323.0
563
47
N87
ICPC
Parkinsonism
108.2
323.0
394
58
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
218.8
323.0
822
172
N04BD02
ATC
rasagiline; oral
232.6
323.0
365
24
N04BC04
ATC
ropinirole; oral
+∞
323.0
1047
16
193
Kela drug reimbursment
Rasagiline
224.7
306.2
304
19
N04BC05
ATC
pramipexole; oral
21.2
303.5
487
412
N04BC09
ATC
rotigotine; transdermal
156.0
195.3
202
16
N04BX02
ATC
entacapone; oral
229.7
120.4
122
6
R25.1
ICD-10 Finland
Tremor, unspecified
16.3
114.1
191
141
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
400.9
110.5
109
*
N03AE01
ATC
clonazepam; systemic
9.8
108.3
236
302
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
64.4
99.5
115
20
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
179.9
80.3
83
5
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
15.4
77.9
132
97
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
29.3
74.3
101
38
N05AH04
ATC
quetiapine; oral
4.4
68.9
290
832
N04BB01
ATC
amantadine; oral
20.1
68.2
104
57
N06DA03
ATC
rivastigmine; oral, transdermal
9.1
63.8
141
176
G04BD12
ATC
mirabegron; oral
4.0
54.3
249
754
N04AA02
ATC
biperiden; systemic
15.7
52.3
87
60
C07AA05
ATC
propranolol; systemic
3.4
50.4
300
1113
N03AX12
ATC
gabapentin; oral
3.4
48.2
279
1012
XA800
NOMESCO Finland
Neuropsychological investigation
7.2
46.2
117
179
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
37.4
39.4
50
14
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.5
38.1
428
2288
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
380.1
37.2
37
*
SPAT1229
SPAT
Assessment of need for aid
3.8
37.1
174
523
N04BC06
ATC
cabergoline; oral (dopamine agonists)
33.5
34.7
45
14
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.7
34.0
162
491
AA1AD
NOMESCO Finland
CT of head and brain
2.4
33.2
361
1868
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
21.8
30.2
44
21
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
28.8
201
799
R1250
NOMESCO Finland
Evaluation of functional capability
7.3
27.9
68
98
L28
ICPC
Limited function/disability (L)
2.5
27.3
245
1127
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.6
26.4
95
221
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
26.2
256
1226
XF606
NOMESCO Finland
Ortostatic test
14.9
25.8
43
30
N06AX11
ATC
mirtazapine; oral
2.1
25.8
387
2270
A28
ICPC
Limited function/disability NOS
2.5
25.4
222
1001
N04BC02
ATC
pergolide; oral
+∞
25.1
24
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.4
24.9
128
409
SPAT1216
SPAT
Assessment of functional ability
2.4
24.8
236
1112
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
10.0
24.5
49
51
M48.0
ICD-10 Finland
Spinal stenosis
2.5
23.6
204
911
N19
ICPC
Speech disorder
9.3
23.5
49
55
I95.1
ICD-10 Finland
Orthostatic hypotension
5.0
23.4
78
167
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
41.1
22.7
28
7
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.7
22.7
103
297
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.4
22.7
224
1071
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.1
22.5
134
475
R53
ICD-10 Finland
Malaise and fatigue
2.3
22.1
251
1281
A06AD11
ATC
lactulose; oral
2.4
21.8
202
932
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.3
21.3
112
363
R47.1
ICD-10 Finland
Dysarthria and anarthria
13.9
20.6
35
26
N06AB10
ATC
escitalopram; oral
2.4
20.4
205
982
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
33.3
20.2
26
8
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
4.7
19.5
67
149
K59.09
ICD-10 Finland
Constipation, unspecified
3.3
19.4
103
336
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.6
18.6
65
147
R35
ICD-10 Finland
Polyuria
3.1
18.6
110
387
N03AX16
ATC
pregabalin; oral
2.0
18.3
296
1739
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
44.8
18.3
22
5
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.7
18.0
52
95
G25.0
ICD-10 Finland
Essential tremor
4.9
17.9
59
126
N04BC07
ATC
apomorphine; parenteral
+∞
17.8
17
*
N05BA04
ATC
oxazepam; oral
2.0
17.2
276
1608
R4130
NOMESCO Finland
Speech therapy
5.3
17.0
52
102
SPAT1234
SPAT
Support of social functional capacity
3.4
16.8
85
268
H02AA02
ATC
fludrocortisone; oral
10.6
16.8
32
31
AA5QN
NOMESCO Finland
NA
+∞
16.7
16
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
+∞
16.7
16
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.8
16.7
112
427
U04
ICPC
Incontinence urine
3.6
16.6
76
221
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.1
16.4
93
317
R60.0
ICD-10 Finland
Localized oedema
2.4
16.3
154
710
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.9
16.3
104
385
N08
ICPC
Abnormal involuntary movements
60.9
15.8
18
*
N04BX04
ATC
opicapone; oral
162.2
15.5
16
*
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.6
15.4
119
493
G02CB01
ATC
bromocriptine; systemic
8.3
15.1
33
41
M54.4
ICD-10 Finland
Lumbago with sciatica
2.1
14.4
186
990
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.7
14.3
64
183
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
14.1
337
2228
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
14.0
207
1161
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.9
13.9
89
329
N28
ICPC
Limited function/disability (N)
5.7
13.8
39
70
D21
ICPC
Swallowing problem
6.7
13.6
34
52
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
76.1
13.6
15
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
13.3
100
408
R1260
NOMESCO Finland
Evaluation of communicative skills
5.6
13.2
38
70
L03
ICPC
Low back symptom/complaint
1.8
12.9
263
1644
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.0
12.9
51
132
M54.5
ICD-10 Finland
Low back pain
1.7
12.6
332
2242
A04
ICPC
Weakness/tiredness general
2.2
12.6
141
704
K02.1
ICD-10 Finland
Caries of dentine
1.6
12.5
536
4132
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
12.5
274
1750
R23
ICPC
Voice symptom/complaint
5.9
12.5
34
59
N04
ICPC
Restless legs
13.4
12.5
21
16
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.7
12.1
34
61
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
6.1
12.0
32
54
N06AX21
ATC
duloxetine; oral
2.3
12.0
121
574
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
11.9
11.8
21
18
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
11.7
194
1129
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
11.2
11.6
21
19
G90.3
ICD-10 Finland
Multi-system degeneration
+∞
11.5
11
*
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
121.2
11.4
12
*
M41.9
ICD-10 Finland
Scoliosis, unspecified
6.1
11.4
30
50
G25.2
ICD-10 Finland
Other specified forms of tremor
12.0
11.3
20
17
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
11.3
134
685
N02BE01
ATC
paracetamol; systemic, rectal
1.8
11.1
897
8035
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.0
10.9
62
212
SPAT1301
SPAT
No procedures
1.6
10.9
358
2545
N29
ICPC
Neurological sympt/complt other
4.4
10.9
38
88
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
10.8
122
607
S72.0
ICD-10 Finland
Fracture of neck of femur
3.3
10.7
52
161
D12
ICPC
Constipation
3.5
10.6
49
146
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.1
10.5
118
588
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
14.4
10.5
17
12
M03BX01
ATC
baclofen; systemic
6.0
10.5
28
48
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.2
10.4
54
176
M79.6
ICD-10 Finland
Pain in limb
1.6
10.3
377
2749
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.5
10.2
46
134
K59.0
ICD-10 Finland
Constipation
2.6
10.1
74
298
G04BD09
ATC
trospium; oral
3.7
10.0
42
116
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
9.9
98
460
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
9.9
501
3932
EBA00
NOMESCO Finland
Extraction of tooth
1.6
9.9
326
2311
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
8.2
9.8
21
26
S01.0
ICD-10 Finland
Open wound of scalp
2.3
9.8
92
423
N06AX16
ATC
venlafaxine; oral
2.0
9.7
130
695
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
9.4
119
623
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
100.9
9.4
10
*
N04BC01
ATC
bromocriptine; oral
100.9
9.4
10
*
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
100.9
9.4
10
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.4
9.4
76
324
N86
ICPC
Multiple sclerosis
10.8
9.3
17
16
N30.0
ICD-10 Finland
Acute cystitis
1.9
9.2
138
773
C03CA01
ATC
furosemide; systemic
1.6
9.2
320
2294
H50.52
ICD-10 Finland
Exophoria
7.8
9.1
20
26
R44.3
ICD-10 Finland
Hallucinations, unspecified
15.7
9.0
14
9
G04BD08
ATC
solifenacin; oral
2.2
9.0
96
467
L17
ICPC
Foot/toe symptom/complaint
1.6
8.9
269
1858
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.6
8.8
29
64
G25
ICD-10 Finland
Other extrapyramidal and movement disorders
50.4
8.7
10
*
R5110
SPAT
NA
3.3
8.6
41
126
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.2
8.6
31
75
R13
ICD-10 Finland
Dysphagia
2.3
8.6
79
358
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
8.5
529
4285
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
4.4
8.5
29
67
K07
ICPC
Swollen ankles/oedema
2.6
8.4
59
234
R41.0
ICD-10 Finland
Disorientation, unspecified
3.3
8.4
41
129
F0232, G20
ICD-10 Finland
NA
+∞
8.3
8
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
8.3
223
1487
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
5.3
8.3
24
46
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
6.6
8.2
20
31
WX110
NOMESCO Finland
Local anesthesy
1.5
8.2
654
5560
R60.9
ICD-10 Finland
Oedema, unspecified
2.4
8.0
67
290
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
8.0
160
981
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
8.0
98
508
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
7.9
647
5506
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
7.7
238
1644
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.3
7.7
68
305
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.7
7.6
49
186
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.0
7.5
41
140
WX290
NOMESCO Finland
Other blockade of nerve
1.5
7.5
357
2714
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
7.4
144
877
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
80.6
7.4
8
*
R44.1
ICD-10 Finland
Visual hallucinations
7.7
7.4
16
21
SPAT1172
SPAT
Guidance concerning hydration
3.2
7.4
36
114
W19
ICD-10 Finland
Unspecified fall
1.9
7.4
101
546
M03BX02
ATC
tizanidine; oral
1.4
7.3
577
4836
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
+∞
7.3
7
*
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
7.3
573
4806
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
30.2
7.2
9
*
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.9
7.0
108
610
Y94.0
ICD-10 Finland
Accident at home
4.2
7.0
25
61
J01EA01
ATC
trimethoprim; systemic
1.5
7.0
234
1642
AA1AA
NOMESCO Finland
Head X-ray examination
5.9
6.9
18
31
RF120
NOMESCO Finland
NA
4.7
6.9
22
48
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
5.1
6.8
20
40
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
6.8
135
827
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
6.1
6.8
17
28
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.4
6.8
30
89
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
4.3
6.6
23
55
SCA03
NOMESCO Finland
Preventive oral health care, extensive
2.7
6.6
43
164
G81.9
ICD-10 Finland
Hemiplegia, unspecified
6.9
6.5
15
22
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
3.4
6.5
29
87
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.0
6.4
80
417
SPAT1101
SPAT
Orthostatic test
2.3
6.4
57
256
N99
ICPC
Neurological disease other
4.7
6.4
20
43
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.1
6.4
67
327
SPAT1263
SPAT
Sampling
1.4
6.3
421
3388
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
6.3
48
201
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
9.3
6.3
12
13
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
6.3
509
4242
S20
ICPC
Corn/callosity
3.1
6.3
32
106
RF433
NOMESCO Finland
NA
18.1
6.3
9
5
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
6.3
135
848
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.7
6.3
41
158
N04BX01
ATC
tolcapone; oral
+∞
6.3
6
*
K11.72
ICD-10 Finland
Xerostomia
26.8
6.2
8
*
SPAT1310
SPAT
Counselling related to known health issue
1.4
6.2
320
2456
R42
ICD-10 Finland
Dizziness and giddiness
1.5
6.2
222
1583
NAG66
NOMESCO Finland
Posterior interbody fusion of lumbar spine, 2 vertebrae
5.8
6.2
16
28
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.1
6.1
69
347
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.0
6.1
77
404
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
39
38
10.57
35.25
1.8
1.2
115.68
138.87
nmol/l
0.24
19
28
897
6989
2.10
27.55
6.1
4.7
2711.56
2123.82
e6/l
0.08
18
107
515
3489
1.83
22.36
2.7
2.2
255.59
226.95
u/l
0.29
487
3269
365
2251
1.89
21.15
5.1
4.3
1.02
1.02
kg/l
0.62
54
318
671
5058
1.73
19.11
4.8
3.9
0.00
0.00
estimate
0.00
127
952
377
2434
1.80
18.39
1.7
1.7
388.94
20986205.16
pmol/l
1.66
321
1968
535
3869
1.69
17.09
5.2
4.2
—
—
—
0
0
663
5073
1.68
17.06
6.1
5.2
0.00
0.00
estimate
0.00
129
965
414
2802
1.73
16.85
5.4
4.2
0.00
0.00
estimate
0.50
122
918
667
5130
1.67
16.67
4.9
3.9
0.00
0.01
estimate
0.80
129
927
342
2222
1.75
15.94
1.9
1.8
1259.40
1180.62
nmol/l
0.93
269
1651
404
2799
1.67
14.64
1.6
1.6
18.94
20.35
nmol/l
0.53
364
2346
703
5669
1.57
13.00
5.2
7.4
1.21
1.21
mmol/l
0.20
589
4823
609
4757
1.56
12.93
2.2
2.0
89.21
94.72
pmol/l
2.57
360
2470
783
6502
1.58
12.50
4.7
5.2
6.38
6.81
mmol/l
11.10
740
6141
565
4364
1.55
12.44
4.7
4.0
44.27
50.10
ng/l
0.23
439
3321
147
804
1.94
11.68
6.2
7.7
25.61
24.60
mmol/l
3.20
137
749
619
4933
1.52
11.47
4.1
5.1
35.38
35.00
g/l
0.98
574
4593
530
4115
1.51
10.93
3.0
2.8
128.75
155.84
ug/l
1.82
479
3709
223
1418
1.70
10.75
4.8
8.2
5.20
5.11
kpa
0.72
212
1361
223
1419
1.70
10.72
4.8
8.1
12.41
12.00
kpa
0.51
212
1362
644
5233
1.49
10.49
4.7
6.5
1.20
1.21
mmol/l
1.28
583
4740
222
1422
1.69
10.39
4.8
8.1
2.05
1.17
mmol/l
2.96
183
1113
411
3136
1.47
8.72
3.6
3.3
0.35
0.46
e6/l
0.79
325
2407
215
1451
1.59
8.04
8.9
7.9
—
—
—
0
0
865
7646
1.46
7.93
4.1
3.9
15.32
15.00
pmol/l
2.81
774
6815
194
1289
1.60
7.73
5.2
8.5
96.14
95.55
%
1.01
184
1245
321
2392
1.47
7.49
2.8
2.6
5.09
4.72
e6/l
0.25
285
2113
363
2799
1.42
6.98
2.3
2.2
2.82
3.06
mg/l
1.55
310
2362
1087
10167
1.69
6.94
19.2
16.4
27.75
25.97
mg/l
0.87
925
8170
270
1978
1.47
6.80
3.1
2.8
1.50
1.07
e6/l
0.67
175
1170
263
1920
1.47
6.74
1.9
1.9
—
—
—
0
0
298
2233
1.44
6.65
1.9
1.6
1.36
1.40
mg/l
0.09
236
1747
426
3402
1.39
6.61
3.8
3.4
53.73
84.31
e6/l
0.61
337
2662
195
1360
1.52
6.21
1.9
1.8
—
—
—
0
0
194
1361
1.51
6.01
1.9
1.9
—
—
—
0
0
112
690
1.69
6.00
1.4
1.5
—
—
—
0
0
175
1202
1.53
5.98
5.5
8.9
124.39
121.08
g/l
1.43
166
1159
1008
9339
1.48
5.92
5.1
4.7
1.93
2.12
mu/l
0.80
912
8390
464
3810
1.35
5.89
2.6
3.5
2.34
2.35
mmol/l
1.53
407
3281
442
3609
1.35
5.80
2.9
3.0
978.65
1376.77
ng/l
2.13
370
3109
595
5080
1.34
5.78
4.2
4.2
—
—
—
0
0
861
7801
1.36
5.42
4.1
4.3
11.80
13.35
mm/h
2.15
791
7158
419
3443
1.33
5.13
2.4
2.6
54.57
57.62
u/l
0.64
391
3151
909
8377
1.34
4.62
6.0
8.1
80.64
79.03
u/l
0.48
847
7855
28
119
2.39
4.34
1.7
1.7
—
—
—
0
0
99
1472
0.64
4.29
4.3
4.8
34.11
32.46
%
0.76
62
964
237
1851
1.35
3.96
2.3
1.9
29.54
29.78
s
0.22
229
1790
19
70
2.74
3.93
1.2
1.8
—
—
—
0
0
1124
10814
1.56
3.85
22.1
19.3
139.82
139.66
mmol/l
1.47
1104
10551
1125
10841
1.54
3.64
22.1
19.5
3.96
3.99
mmol/l
5.46
1105
10563
141
1027
1.42
3.59
3.1
2.9
163.19
207.61
ng/l
1.11
132
940
272
2196
1.31
3.59
2.6
3.2
2.44
2.46
mmol/l
3.23
237
1942
317
3789
0.78
3.57
3.8
4.1
8.21
8.59
mg/mmol
0.04
197
2405
23
99
2.35
3.51
1.4
1.7
—
—
—
0
0
933
9847
0.77
3.46
3.7
4.3
1.15
1.30
mmol/l
11.74
822
8849
885
8244
1.27
3.41
21.2
20.0
13.60
13.82
%
6.02
870
8058
334
2796
1.27
3.30
3.6
4.1
86.73
87.07
%
0.09
321
2731
112
801
1.44
3.17
4.8
9.7
0.75
0.69
%
0.99
112
794
576
5144
1.23
3.14
2.5
2.4
—
—
—
0
0
112
803
1.44
3.13
4.9
9.7
93.97
93.85
%
0.10
112
796
230
1850
1.30
3.10
3.5
3.0
3.04
1.95
e6/l
0.96
133
1044
92
1298
0.68
3.07
3.1
4.3
4.06
23.30
ug/l
2.15
72
1073
112
808
1.43
3.03
4.8
9.5
1.30
1.34
%
0.26
112
802
31
161
1.95
3.01
1.5
1.3
29.31
30.73
iu/l
0.10
31
134
56
349
1.63
2.98
1.1
1.3
—
—
—
0
0
144
1094
1.36
2.88
3.0
2.5
6.13
7.29
ug/l
0.51
114
974
934
9801
0.79
2.81
16.3
15.3
81.95
76.31
ml/min/173m2
18.36
798
8126
114
837
1.40
2.81
1.8
1.6
—
—
—
0
0
264
2190
1.26
2.78
4.4
4.0
41.54
392.19
ng/l
9.96
222
1827
974
10160
0.79
2.68
4.1
4.8
1.45
1.44
mmol/l
0.21
871
9200
46
283
1.65
2.61
8.2
8.6
105.00
105.46
mmol/l
0.24
40
254
637
5815
1.20
2.59
4.4
6.6
11.21
11.60
umol/l
0.47
604
5520
11
271
0.40
2.51
1.3
1.2
—
—
—
0
0
317
3661
0.82
2.44
3.0
3.2
7.72
7.46
mmol/l
0.51
260
3027
986
10247
0.80
2.41
4.2
4.8
4.45
4.54
mmol/l
2.18
889
9356
476
4266
1.19
2.29
2.2
2.2
74.63
78.72
nmol/l
2.72
412
3738
73
516
1.44
2.26
6.3
6.1
1.50
1.61
%
0.68
66
483
312
3584
0.83
2.24
3.0
3.3
1376.53
313.30
mg/l
1.26
196
2301
75
535
1.43
2.22
2.0
1.9
1.02
1.88
ug/l
0.71
61
476
73
521
1.43
2.16
1.5
1.2
279.25
196.41
u/ml
0.44
66
474
1013
10473
0.80
2.16
4.7
5.4
2.60
2.66
mmol/l
1.10
911
9514
7
178
0.39
2.03
1.0
1.1
—
—
—
0
0
13
271
0.47
1.99
1.5
1.5
—
—
—
0
0
29
474
0.60
1.99
2.6
3.6
44.11
3075.99
u/ml
0.80
19
401
98
750
1.33
1.93
1.9
1.7
—
—
—
0
0
149
1208
1.27
1.91
4.2
3.5
—
—
—
0
0
41
613
0.66
1.91
1.8
1.8
—
—
—
0
0
950
9861
0.83
1.91
5.9
6.4
40.09
40.50
mmol/mol
0.78
865
9040
8
30
2.68
1.72
1.4
1.2
—
—
—
0
0
199
1687
1.21
1.71
1.3
1.3
24.58
39.56
iu/ml
1.76
49
539
116
929
1.28
1.67
2.4
4.1
1.23
1.22
mmol/l
0.08
94
815
112
900
1.27
1.58
3.4
3.0
65.74
62.06
ml/min/173m2
0.38
43
371
43
299
1.45
1.53
1.2
1.2
—
—
—
0
0
9
184
0.49
1.51
1.0
1.2
—
—
—
0
0
90
708
1.29
1.50
2.5
2.5
36.03
16.26
au/ml
—
6
23
22
131
1.69
1.50
1.5
1.4
—
—
—
0
0
14
72
1.96
1.49
1.3
1.5
—
—
—
0
0
14
72
1.96
1.49
1.3
1.5
—
—
—
0
0
43
301
1.44
1.48
1.2
1.2
—
—
—
0
0
22
352
0.62
1.45
1.9
1.7
—
—
—
0
0
19
314
0.60
1.43
1.8
2.5
336.00
108.32
ug/min
0.38
11
189
126
1041
1.23
1.41
1.8
2.3
224.13
143.15
ug/g
0.80
104
820
218
1900
1.18
1.40
2.2
3.4
0.83
0.82
mmol/l
1.72
205
1780
205
1781
1.18
1.37
2.3
2.6
12.66
12.79
umol/l
0.08
181
1644
365
3314
1.15
1.37
3.0
3.3
27.70
33.56
u/l
5.58
342
3138
191
1650
1.19
1.36
2.2
2.5
2.31
2.28
g/l
0.28
166
1532
13
68
1.92
1.33
2.4
2.4
—
—
—
0
0
20
315
0.63
1.26
2.1
2.0
100.85
88.02
%
2.30
20
300
15
253
0.59
1.24
1.2
1.3
—
—
—
0
0
37
263
1.42
1.22
1.6
1.6
—
—
—
0
0
55
418
1.33
1.21
1.2
1.3
—
—
—
0
0
127
1070
1.21
1.20
2.3
2.7
63.96
70.26
e9/l
1.30
102
834
83
1021
0.80
1.19
1.6
1.7
1.38
1.58
%
2.78
73
852
74
589
1.27
1.18
3.2
3.5
25.73
25.11
mmol/l
1.02
68
571
36
257
1.41
1.16
2.0
2.4
131.07
129.45
g/l
0.18
27
188
0
35
0.00
1.15
0.0
1.3
—
9.54
—
0
35
83
673
1.25
1.14
4.3
8.3
25.60
24.91
mmol/l
1.12
83
668
0
36
0.00
1.14
0.0
2.1
—
—
—
0
0
7
137
0.51
1.10
1.0
1.1
—
—
—
0
0
160
1390
1.17
1.09
2.5
2.6
1.63
1.82
%
1.81
140
1239
39
287
1.37
1.08
1.3
1.3
541.28
542.38
mg/l
0.01
39
270
641
6095
1.11
1.05
7.9
9.5
4.23
4.19
e9/l
0.15
553
5318
8
147
0.54
1.04
1.3
1.6
—
—
—
0
0
8
147
0.54
1.04
1.3
1.6
—
—
—
0
0
8
148
0.54
1.04
1.3
1.5
—
—
—
0
0
8
148
0.54
1.04
1.3
1.5
—
—
—
0
0
8
148
0.54
1.04
1.3
1.5
—
—
—
0
0
5
22
2.28
1.03
1.2
1.3
—
—
—
0
0
35
472
0.73
1.02
1.8
1.9
33.27
39.24
u/l
1.56
29
409
403
3744
1.11
1.01
4.3
4.6
21.55
21.23
%
0.17
202
1928
121
1035
1.19
1.00
2.0
3.0
66.01
66.42
g/l
0.22
98
947
1135
11190
1.23
0.98
27.6
24.2
132.08
134.94
g/l
9.07
1118
11005
11
61
1.81
0.98
1.0
1.5
—
218.57
—
0
7
220
1980
1.14
0.95
1.2
1.2
1.14
1.50
u/ml
0.50
60
514
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
454
0.74
0.94
2.1
2.6
0.47
0.34
u/ml
1.16
18
260
34
251
1.36
0.94
1.4
1.3
2.61
45.96
e6/l
1.11
28
194
70
571
1.24
0.94
2.7
2.6
0.68
0.66
%
0.28
65
552
7
37
1.90
0.94
2.7
2.1
33.49
239.47
ug/l
—
7
31
1134
11185
1.22
0.93
27.5
24.1
242.32
243.16
e9/l
0.17
1113
10870
8
146
0.54
0.93
1.3
1.5
—
—
—
0
0
91
1076
0.83
0.92
4.7
7.6
9.66
10.30
mmol/l
0.42
84
1031
1134
11188
1.22
0.91
27.5
24.1
4.39
4.46
e12/l
5.21
1109
10838
11
63
1.75
0.90
1.5
1.8
16.88
17.49
nmol/l
0.09
11
54
10
56
1.79
0.88
1.8
1.9
—
—
—
0
0
921
8967
1.11
0.87
19.2
17.7
38.86
39.35
%
0.68
511
5811
271
2948
0.90
0.86
1.5
1.7
1.20
1.36
mmol/l
3.31
220
2414
122
1063
1.16
0.84
4.5
7.4
1.31
1.39
mmol/l
0.41
117
1029
1133
11188
1.20
0.82
27.5
24.2
6.56
6.77
e9/l
2.73
1107
10839
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
8
47
1.71
0.80
1.1
1.1
—
70.00
%
—
0
6
33
251
1.32
0.79
1.3
1.2
3.60
3.83
mmol/l
0.93
33
234
14
90
1.56
0.78
1.3
1.8
1.17
2.21
u/field
—
6
34
5
100
0.50
0.77
1.4
2.3
407.80
640.83
ml
—
5
63
293
2717
1.10
0.76
2.4
2.5
—
—
—
0
0
41
324
1.27
0.75
1.7
1.5
—
—
—
0
0
250
2710
0.90
0.75
3.0
3.2
0.65
0.76
ug/l
2.49
166
1884
5
24
2.09
0.74
1.8
1.3
—
—
—
0
0
14
208
0.67
0.74
2.1
3.8
59.36
59.04
%
0.05
14
208
8
135
0.59
0.73
1.3
1.1
—
—
—
0
0
36
281
1.29
0.73
1.8
1.6
—
—
—
0
0
33
422
0.78
0.72
2.8
4.0
22.71
87.68
mg/l
1.37
27
346
33
421
0.78
0.71
2.8
4.0
36.11
67.08
mg/l
1.25
27
343
5
26
1.93
0.70
1.0
1.8
—
—
—
0
0
14
94
1.50
0.67
1.0
1.0
—
—
—
0
0
32
250
1.29
0.66
1.6
1.6
—
—
—
0
0
17
120
1.42
0.64
1.1
1.1
—
—
—
0
0
39
314
1.25
0.64
1.8
1.7
12716.33
13764.58
e6/l
0.04
30
229
44
360
1.23
0.63
1.1
1.2
0.26
1.13
u/ml
—
5
29
6
103
0.58
0.62
1.0
1.7
—
—
—
0
0
11
71
1.55
0.62
1.0
1.5
—
21.82
—
0
11
10
63
1.59
0.62
2.2
1.8
—
—
—
0
0
172
1571
1.11
0.61
5.2
7.2
104.85
104.19
mmol/l
1.02
167
1531
8
50
1.60
0.61
1.0
1.4
0.25
0.16
nmol/l
—
8
33
14
198
0.70
0.60
2.0
3.5
4.31
4.46
e9/l
0.12
14
198
0
20
0.00
0.60
0.0
2.9
—
37.86
—
0
7
12
80
1.51
0.60
1.1
1.4
—
—
—
0
0
171
1565
1.11
0.59
2.3
2.6
22.89
22.61
%
0.07
129
1327
10
64
1.57
0.58
1.5
1.4
—
—
—
0
0
10
64
1.57
0.58
1.5
1.4
—
—
—
0
0
123
1106
1.12
0.58
3.0
3.8
5.79
5.84
kpa
0.22
118
1075
53
448
1.19
0.57
2.3
3.0
3.26
3.13
g/l
0.29
37
356
5
89
0.56
0.56
1.0
1.1
—
—
—
0
0
28
221
1.27
0.55
1.1
1.1
—
—
—
0
0
22
168
1.32
0.55
1.3
1.5
—
—
—
0
0
1008
10224
0.92
0.53
4.7
5.1
5.93
6.05
mmol/l
3.37
898
9184
134
1219
1.11
0.53
1.8
2.9
5.23
8.55
umol/l
6.46
113
1086
27
214
1.27
0.52
1.4
1.3
—
—
—
0
0
62
538
1.16
0.51
2.8
3.3
4.35
4.39
pmol/l
0.14
56
468
22
280
0.78
0.50
4.9
3.1
0.79
0.83
nmol/l
0.24
15
216
39
326
1.20
0.49
1.4
1.5
295.15
275.97
ug/g
0.23
26
198
30
244
1.24
0.48
1.2
1.5
—
—
—
0
0
61
533
1.15
0.47
1.2
1.2
40.22
148.46
iu/ml
4.28
29
199
7
48
1.46
0.47
1.3
1.0
—
—
—
0
0
32
385
0.83
0.46
1.7
1.6
—
101.43
—
0
14
114
1040
1.11
0.45
1.3
1.4
—
—
—
0
0
10
69
1.45
0.44
1.2
1.3
43.68
37.92
u/l
—
10
52
7
51
1.37
0.44
1.3
1.3
—
—
—
0
0
94
851
1.11
0.43
2.3
2.2
11.99
12.75
nmol/l
0.44
85
737
9
131
0.68
0.43
8.3
4.2
—
—
—
0
0
5
31
1.62
0.43
1.6
1.1
—
—
—
0
0
5
31
1.62
0.43
1.6
1.1
—
—
—
0
0
6
95
0.63
0.42
1.0
1.2
2.20
1.49
nmol/l
—
6
83
0
16
0.00
0.41
0.0
9.9
—
5.88
—
0
16
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
479
4633
1.06
0.41
4.7
5.3
2.37
2.83
ug/l
0.65
416
4111
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
98
893
1.11
0.40
2.4
3.9
89.68
93.19
ng/l
0.13
82
778
0
18
0.00
0.40
0.0
1.2
—
17.42
—
0
12
119
1098
1.09
0.39
3.0
3.8
2.62
2.01
mmol/l
0.83
95
878
17
133
1.28
0.38
2.1
2.6
—
—
—
0
0
14
181
0.77
0.38
1.3
2.8
—
1970.14
—
0
14
26
216
1.21
0.37
1.2
1.7
4.68
5.50
iu/l
0.16
11
68
655
6402
1.05
0.36
2.8
3.3
45.76
55.03
u/l
0.89
607
5879
23
190
1.21
0.35
1.3
1.5
—
—
—
0
0
54
481
1.13
0.34
2.3
2.9
7.38
7.42
g/l
0.04
37
364
54
481
1.13
0.34
2.3
2.9
3.68
3.85
g/l
0.42
37
352
54
481
1.13
0.34
2.2
2.9
—
—
—
0
0
173
1633
1.07
0.33
1.3
1.2
6.56
14.02
u/ml
1.31
69
592
169
1595
1.07
0.33
19.9
26.9
1.36
1.35
inr
0.04
14
213
41
362
1.14
0.30
2.5
2.9
0.00
0.03
g/l
1.09
36
335
10
130
0.77
0.29
1.3
1.8
—
—
—
0
0
35
398
0.88
0.29
1.0
1.0
—
—
—
0
0
27
232
1.17
0.28
3.9
3.8
47.67
26.52
mg/l
0.89
15
139
132
1400
0.94
0.28
2.7
4.2
224.98
248.20
u/l
2.27
119
1333
10
129
0.77
0.28
1.2
1.1
119.00
116.21
%
—
10
118
12
150
0.80
0.27
1.2
1.6
71.33
64.12
%
—
6
100
22
187
1.18
0.26
1.0
1.1
—
—
—
0
0
20
169
1.19
0.26
1.2
1.7
—
—
—
0
0
12
149
0.80
0.26
1.2
1.4
68784.29
119092.00
e6/l
—
7
86
36
320
1.13
0.25
1.6
1.8
—
—
—
0
0
21
179
1.18
0.25
1.6
1.4
—
—
—
0
0
38
340
1.12
0.24
1.4
1.4
—
—
—
0
0
172
1798
0.95
0.24
1.3
1.5
2.80
2.68
g/l
0.10
86
1050
15
124
1.21
0.24
1.4
1.5
—
—
—
0
0
1096
10897
1.06
0.22
10.1
11.5
19.05
25.93
u/l
50.58
1019
10475
38
343
1.11
0.22
2.6
3.0
0.00
0.00
g/l
0.00
33
317
17
144
1.18
0.22
1.5
1.3
0.94
0.38
nmol/l
—
10
12
30
267
1.13
0.21
1.5
3.0
26.91
32.54
umol/l
0.86
23
222
42
382
1.10
0.21
2.5
2.8
37.60
37.29
g/l
0.13
36
332
5
42
1.19
0.21
1.4
1.2
127.80
241.56
iu/ml
—
5
42
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
15.60
—
0
12
5
43
1.16
0.21
1.2
1.7
2.06
5.64
nmol/l
—
5
36
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
6
49
1.23
0.20
1.0
1.2
—
—
—
0
0
14
164
0.85
0.18
1.2
1.4
3348.89
1660.47
e6/l
—
9
117
49
454
1.08
0.18
2.3
3.0
9.39
10.57
g/l
1.51
38
386
7
58
1.21
0.18
1.0
1.2
—
—
—
0
0
24
214
1.12
0.17
1.3
1.5
—
—
—
0
0
25
224
1.12
0.17
1.0
1.3
—
402.86
—
0
7
45
417
1.08
0.17
2.4
3.1
0.41
1.69
g/l
2.28
37
365
5
66
0.76
0.17
1.2
1.9
—
—
—
0
0
5
66
0.76
0.17
1.2
1.9
—
—
—
0
0
5
66
0.76
0.17
1.2
1.9
—
—
—
0
0
5
66
0.76
0.17
1.2
1.9
—
—
—
0
0
5
67
0.75
0.17
1.6
1.2
—
—
—
0
0
5
67
0.75
0.17
1.6
1.2
—
—
—
0
0
5
70
0.71
0.16
1.6
1.1
74.60
81.37
u/l
—
5
62
37
340
1.09
0.16
2.7
3.0
0.00
0.00
g/l
0.00
32
316
9
83
1.08
0.14
1.1
1.2
2.00
1.96
mmol/l
—
9
77
13
112
1.16
0.14
1.4
2.6
—
—
—
0
0
29
316
0.92
0.14
1.3
1.6
0.50
0.09
iu/ml
0.95
12
57
25
227
1.10
0.14
1.3
1.4
—
—
—
0
0
25
227
1.10
0.14
1.3
1.4
—
—
—
0
0
8
96
0.83
0.13
1.4
1.2
15.38
11.62
u/l
—
8
87
8
97
0.82
0.13
1.3
1.1
98.00
94.95
%
—
8
92
8
97
0.82
0.13
1.6
1.4
13.00
13.11
u/l
—
8
91
35
377
0.93
0.13
1.7
1.5
—
—
—
0
0
16
179
0.89
0.12
1.7
1.3
—
—
—
0
0
52
548
0.95
0.12
2.6
3.9
25.13
24.21
mmol/l
0.83
43
496
101
975
1.04
0.12
2.1
2.3
383.61
366.53
nmol/l
0.32
93
888
19
208
0.91
0.10
1.2
1.3
—
—
—
0
0
19
173
1.10
0.10
1.4
1.5
—
—
—
0
0
113
1163
0.97
0.10
1.3
1.3
—
—
—
0
0
5
44
1.14
0.10
1.0
1.3
—
—
—
0
0
31
291
1.07
0.09
1.2
1.7
—
—
—
0
0
5
48
1.04
0.09
1.4
1.3
—
—
—
0
0
49
468
1.05
0.09
1.8
2.0
—
—
—
0
0
6
58
1.03
0.08
1.2
1.4
—
—
—
0
0
6
58
1.03
0.08
1.2
1.4
—
—
—
0
0
7
66
1.06
0.08
1.0
1.3
—
—
—
0
0
47
490
0.96
0.08
3.8
4.2
25.19
25.02
mmol/l
0.15
41
460
6
70
0.86
0.07
1.2
1.4
0.93
1.11
promille
—
6
55
18
194
0.93
0.07
1.1
1.2
—
43.06
—
0
17
9
105
0.86
0.06
1.0
1.2
—
—
—
0
0
20
213
0.94
0.06
1.2
1.8
—
—
—
0
0
11
121
0.91
0.06
1.1
1.3
—
—
—
0
0
100
1020
0.98
0.05
2.5
2.4
35.69
39.73
u/l
0.21
86
862
27
257
1.05
0.05
2.9
2.8
16.63
16.05
%
0.38
19
133
44
428
1.03
0.03
1.8
1.8
—
—
—
0
0
495
4929
1.01
0.03
6.0
6.0
59.87
57.80
%
3.25
445
4592
29
280
1.04
0.03
1.1
1.8
—
—
—
0
0
19
199
0.95
0.03
2.2
2.0
1.73
1.64
mmol/l
0.09
19
193
156
1572
0.99
0.02
3.2
5.9
1.01
1.03
mmol/l
0.38
142
1451
502
5008
1.00
0.01
5.9
6.2
25.63
26.80
%
1.50
450
4638
80
792
1.01
0.01
3.3
3.9
5.11
5.17
kpa
0.26
75
738
41
417
0.98
0.01
1.6
1.6
—
—
—
0
0
13
126
1.03
0.00
1.1
1.8
—
—
—
0
0
13
128
1.02
0.00
1.2
1.1
—
18.43
—
0
6
75
748
1.00
0.00
3.4
3.8
2.07
2.03
mmol/l
0.03
58
577
112
1119
1.00
0.00
1.7
2.2
0.21
0.21
g/l
0.11
101
1046
297
2969
1.00
0.00
2.3
2.9
325.11
6837.80
umol/l
10.22
252
2555
13
133
0.98
0.00
1.1
1.8
—
—
—
0
0
12
115
1.04
0.00
1.1
1.7
—
—
—
0
0
12
115
1.04
0.00
1.1
1.7
—
—
—
0
0
12
115
1.04
0.00
1.1
1.7
—
—
—
0
0
9
97
0.93
0.00
1.3
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
1745.20
—
0
5
0
5
0.00
0.00
0.0
10.2
—
—
—
0
0
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
7
73
0.96
0.00
1.7
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
2.43
—
0
7
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
39.25
—
0
6
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
7
76
0.92
0.00
1.1
1.5
0.87
0.98
g/l
—
7
76
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
44
440
1.00
0.00
3.6
2.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
5
57
0.88
0.00
2.8
2.4
433.80
1572.11
u/ml
—
5
57
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
7.68
—
0
6
0
6
0.00
0.00
0.0
1.0
—
21.42
—
0
6
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
8
86
0.93
0.00
1.6
1.6
—
—
—
0
0
7
71
0.99
0.00
1.0
1.0
—
—
—
0
0
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
58
580
1.00
0.00
1.6
1.9
1.38
1.57
g/l
0.81
48
509
6
66
0.91
0.00
1.8
3.0
—
—
—
0
0
7
73
0.96
0.00
1.7
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
4.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_ROPINIROLE – Use of ropinirole
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).